Myrbetriq is a prescription medicine for adults used to treat overactive bladder (OAB) with symptoms of urgency, frequency and leakage.
Get your first prescription at no cost†
†Subject to eligibility. Restrictions may apply.
Not available to patients paying cash.
Menu
Get your first prescription at no cost† †Subject to eligibility. Restrictions may apply.
Not available to patients paying cash.
Myrbetriq is a prescription medicine for adults used to treat overactive bladder (OAB) with symptoms of urgency, frequency and leakage.

What is Myrbetriq?

The first and only overactive bladder treatment in its class

If you're dealing with urges, frequency and leaks, ask your healthcare professional (HCP) if Myrbetriq® (mirabegron) may be an appropriate treatment option for you.

Myrbetriq (meer-BEH-trick) is a prescription medicine approved by the FDA (Food and Drug Administration) to treat overactive bladder (OAB) with symptoms of urgency, frequency and leakage in adults.

Myrbetriq is the first and only drug in its class for OAB.

Evaluated in clinical studies

The efficacy and safety of Myrbetriq have been evaluated in three 12-week studies and one long‑term (12-month) safety study.

In clinical trials, Myrbetriq was shown to be effective in treating symptoms of OAB within the first several weeks. Those taking Myrbetriq made fewer trips to the bathroom and had fewer leaks than those not taking Myrbetriq. Your results may vary.

If you have the overactive bladder symptoms of urgency, frequency and leakage, speak up and ask your doctor if Myrbetriq may be right for you.

If you have the overactive bladder symptoms of urgency, frequency and leakage, speak up and ask your doctor if Myrbetriq may be right for you.

Get the most out of your next doctor’s visit with this helpful guide.
Go Now

How Myrbetriq Works

Myrbetriq works on a different pathway to increase bladder capacity

Your healthcare professional (HCP) may prescribe Myrbetriq® (mirabegron) for you because you have mentioned that you make too many trips to the bathroom, or have frequent leaks and accidents. Your HCP may also consider Myrbetriq as an option if you have tried other overactive bladder (OAB) management approaches that did not work for you. Before starting Myrbetriq, it's important that you understand how it works.

Myrbetriq is the only OAB treatment option in its class that targets the β3 pathway. When taken as directed, targeting this pathway can help relax the smooth muscle that surrounds the bladder and increase the bladder's ability to store urine. Watch the video below to learn more about how a healthy bladder functions, what causes OAB, and how Myrbetriq may help. After watching the video, if you still have questions or concerns, be sure to ask your HCP.

How Myrbetriq Works Doctor Discussion

Myrbetriq: How it Works

Hear from a doctor – David Staskin, MD, explains the differences between a normal bladder and an overactive bladder, and how Myrbetriq may help.

people like this

Myrbetriq: How it Works

Hear from a doctor – David Staskin, MD, explains the differences between a normal bladder and an overactive bladder, and how Myrbetriq may help.

How Myrbetriq Works

Learn more about Myrbetriq

Watch the video – see how Myrbetriq works in the body to increase the bladder's ability to store urine.

people like this

Learn more about Myrbetriq

Watch the video – see how Myrbetriq works in the body to increase the bladder's ability to store urine.

Think you have symptoms of OAB? Find an OAB specialist now:
Powered by VITALS®

What You Should Know About Taking Myrbetriq

Myrbetriq® (mirabegron) is a prescription medicine for adults used to treat overactive bladder (OAB) with symptoms of urgency, frequency and leakage.

Do not use Myrbetriq if you have an allergy to mirabegron or any of the ingredients in Myrbetriq.

Myrbetriq may cause serious side effects including:

Increased blood pressure: Myrbetriq may cause your blood pressure to increase or make your blood pressure worse if you have a history of high blood pressure. It is recommended that your doctor check your blood pressure while you are taking Myrbetriq.

Inability to empty your bladder (urinary retention): Myrbetriq may increase your chances of not being able to empty your bladder if you have bladder outlet obstruction (BOO), or if you are taking other medicines to treat OAB. Tell your doctor right away if you are unable to empty your bladder.

Angioedema: Myrbetriq may cause an allergic reaction with swelling of the lips, face, tongue, throat, with or without difficulty breathing. Stop using Myrbetriq and tell your doctor right away.

The most common side effects of Myrbetriq include:

  • increased blood pressure
  • common cold symptoms (nasopharyngitis)
  • dry mouth
  • flu symptoms
  • urinary tract infection
  • back pain
  • dizziness
  • joint pain
  • headache
  • constipation
  • sinus (sinus irritation)
  • inflammation of the bladder (cystitis)

Tell your doctor if you have any side effect that bothers you or that does not go away or if you have swelling of the face, lips, tongue, or throat, hives, skin rash or itching while taking Myrbetriq. These are not all the possible side effects of Myrbetriq. For more information, ask your doctor or pharmacist.

Next Section
Talking With
Your Doctor
Prev Section
About
OAB
NEXT: Talking With Your Doctor
Learn why you should talk to your doctor about OAB.
 Menu

Use of Myrbetriq

Myrbetriq® (mirabegron) is a prescription medicine for adults used to treat overactive bladder (OAB) with symptoms of urgency, frequency and leakage.

Important Safety Information

Myrbetriq is not for everyone. Do not take Myrbetriq if you have an allergy to mirabegron or any ingredients in Myrbetriq. Myrbetriq may cause your blood pressure to increase or make your blood pressure worse if you have a history of high blood pressure. It is recommended that your doctor check your blood pressure while you are taking Myrbetriq. Myrbetriq may increase your chances of not being able to empty your bladder. Tell your doctor right away if you have trouble emptying your bladder or you have a weak urine stream.

Myrbetriq may cause allergic reactions that may be serious. If you experience swelling of the face, lips, throat or tongue, with or without difficulty breathing, stop taking Myrbetriq and tell your doctor right away.

Tell your doctor about all the medicines you take including medications for overactive bladder or other medicines such as thioridazine (Mellaril™ and Mellaril-S™), flecainide (Tambocor®), propafenone (Rythmol®), digoxin (Lanoxin®) or solifenacin succinate (VESIcare®). Myrbetriq may affect the way other medicines work, and other medicines may affect how Myrbetriq works.

Before taking Myrbetriq, tell your doctor if you have liver or kidney problems. The most common side effects of Myrbetriq include increased blood pressure, common cold symptoms (nasopharyngitis), dry mouth, flu symptoms, urinary tract infection, back pain, dizziness, joint pain, headache, constipation, sinus irritation, and inflammation of the bladder (cystitis).

For further information, please talk to your healthcare professional and see accompanying Patient Product Information and complete Prescribing Information for Myrbetriq® (mirabegron).

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Myrbetriq® is a registered trademark of Astellas Pharma Inc. All other trademarks or registered trademarks are the property of their respective owners.

You are now leaving myrbetriq.com

You are now leaving myrbetriq.com. The website you are linking to is neither owned nor controlled by Astellas. Astellas is not responsible for the content or services on this site.
Continue to Twitter.

You are now leaving myrbetriq.com. The website you are linking to is not owned by Astellas. Astellas is not responsible for the services on this site.
Continue to Twitter.

You are now leaving myrbetriq.com. The website you are linking to is not owned by Astellas. Astellas is not responsible for the services on this site.
Continue to Facebook.

You are now leaving myrbetriq.com. The website you are linking to is neither owned nor controlled by Astellas. Astellas is not responsible for the content or services on this site.
Continue to FDA Medwatch.

You are now leaving myrbetriq.com. The website you are linking to is neither owned nor controlled by Astellas. Astellas is not responsible for the content or services on this site.
Continue to VITALS®.

Continue Cancel

This website is funded and developed by Astellas Pharma US, Inc. Myrbetriq is a registered trademark of Astellas Pharma Inc.

Our Doctor Conversation Guide can help you start the overactive bladder conversation.

Show it to your doctor at your appointment!

Get your Doctor Conversation Guide